SOURCE: SNN Incorporated

SNN Incorporated

August 31, 2015 08:30 ET

StockNewsNow.com Publishes New SNNLive Video Interview With BioMarker Strategies, LLC

LOS ANGELES, CA--(Marketwired - Aug 31, 2015) - StockNewsNow.com, the Official MicroCap News Source, today published an SNNLive Video Interview with Jerry Parrott, President and CEO of BioMarker Strategies, LLC, a private company, developer of SnapPath®, a cancer diagnostics system, according to the company's website (see here: www.BioMarkerStrategies.com). The video interview was recorded at the BioMaryland Booth at BIO International 2015 in Philadelphia, PA.

Click the following link to watch the SNNLive Video Interview on StockNewsNow.com:

BioMarker Strategies, LLC -- Developer of SnapPath®: Cancer Diagnostics System to Guide Targeted Drug Development and Treatment

You can follow Stock News Now on FACEBOOK, TWITTER, LINKEDIN, YOUTUBE, and STOCKTWITS

Please review important disclosures on our website at: http://stocknewsnow.com/legal.php#disclaimer

About BioMarker Strategies, LLC

BioMarker Strategies has developed SnapPath®, the only cancer diagnostics system that automates and standardizes functional ex vivo profiling of live solid tumor cells from fresh biopsies or other fresh, unfixed samples such as xenografts or tumorgrafts. The Company's PathMAP® Functional Signaling Profiles, created using the SnapPath® system, represent a new class of biomarker tests that are highly predictive of individual response to targeted treatment because they are based on the dynamic and predictive signaling information available only from live cells. PathMAP® Melanoma is currently in development as a companion diagnostic under a National Cancer Institute SBIR Phase II contract, the ultimate goal of which is to prepare for a clinical trial of PathMAP® Melanoma under a Phase IIB NCI contract. Patents for SnapPath® have been allowed and are proceeding to grant in the United States, Europe and Australia, and applications are pending in the U.S. and other countries. Patents for PathMAP® Functional Signaling Profiles have been allowed and are proceeding to grant in Australia and Singapore, and applications are pending in Europe, the U.S. and other countries. For company description and more information, click here: www.BioMarkerStrategies.com

About StockNewsNow.com

StockNewsNow.com is a microcap financial news portal that features news and insights from the microcap and emerging growth financial community. StockNewsNow.com is a multimedia destination hub for information about microcap and emerging growth public and private companies, market events, news, bulletins, stock quotes, expert commentary and company profiles that feature user-generated video, SNN-produced video like SNNLive CEO video interviews, as well as research reports, radio interviews, PowerPoint presentations, articles, and their latest news and headlines. Users can engage directly and share the information provided through social media.

Contact Information